NCT06737094

Brief Summary

Cramps are a frequent and severe complication in CKD patients. Their characteristics : triggering factors, associated factors, are not well known. There is no recognized effective treatment. Using a questionnaire, the investigators wish to determine prevalence, severity and associated factors of cramps in our CKD patients. Better knowledge about cramps in CKD patients will allow to better support, and give a practical tool for treatment evaluation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
250

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2025

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

November 28, 2024

Completed
19 days until next milestone

First Posted

Study publicly available on registry

December 17, 2024

Completed
15 days until next milestone

Study Start

First participant enrolled

January 1, 2025

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2025

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2025

Completed
Last Updated

December 17, 2024

Status Verified

December 1, 2024

Enrollment Period

6 months

First QC Date

November 28, 2024

Last Update Submit

December 11, 2024

Conditions

Keywords

CrampsChronic Kidney DiseasePain

Outcome Measures

Primary Outcomes (1)

  • Prevalence of cramps in CKD III-V patients. Number of patients having cramps / number of questionned patients

    Day 0 - visit of inclusion

Secondary Outcomes (6)

  • Measure of Severity of cramps

    Day 0 - visit of inclusion

  • Frequency of pain intensity

    Day 0 - visit of inclusion

  • Identification of potential triggering factors

    Day 0 - visit of inclusion

  • Identification of associated factors (ionic desorders, medical treatment, degree of CKD, …)

    Day 0 - visit of inclusion

  • Identification of potential improving treatment (medicinal or not)

    Day 0 - visit of inclusion

  • +1 more secondary outcomes

Study Arms (1)

Chronic Kidney Disease (CKD) Patients

Patients with CKD stade III to V (dialysis and non dialysis)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Every patient with Chronic Kidney Disease (non dialysis and dialysis patients)

You may qualify if:

  • Voluntary patients with CKD III to V (GFR\<60ml/mn/1,72M2), including dialysed patients (hemodialysis or peritoneal dialysis).
  • Non opposed to participate to the research.

You may not qualify if:

  • Transplanted patient with functional graft.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Hôpital Pitié Salpêtrière Service de néphrologie

Paris, 75013, France

Location

MeSH Terms

Conditions

Muscle CrampRenal Insufficiency, ChronicPain

Condition Hierarchy (Ancestors)

Muscular DiseasesMusculoskeletal DiseasesNeuromuscular ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsRenal InsufficiencyKidney DiseasesUrologic DiseasesFemale Urogenital DiseasesFemale Urogenital Diseases and Pregnancy ComplicationsUrogenital DiseasesMale Urogenital DiseasesChronic DiseaseDisease AttributesPathologic Processes

Study Officials

  • Marie-Alyette Costa de Beauregard, MD

    Assistance Publique - Hôpitaux de Paris

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Marie-Alyette Costa de Beauregard, MD

CONTACT

Jean-Jacques Boffa, PU-PH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

November 28, 2024

First Posted

December 17, 2024

Study Start

January 1, 2025

Primary Completion

July 1, 2025

Study Completion

July 1, 2025

Last Updated

December 17, 2024

Record last verified: 2024-12

Data Sharing

IPD Sharing
Will not share

Locations